Zainab Mustafa Mahdi

College of Pharmacy, University of Tikrit, Salahaldeen, Iraq

Publications

  • Research Article   
    Estimated doses of folinic acid after methotrexate high dose in hematologic malignancies
    Author(s): Zainab Mustafa Mahdi*

    Folinic acid is a metabolically active reduced form of folate that bypasses dihydrofolate reductase. Folate supplementation indications include the prevention of several diseases such as ulcerative colitis, neural tube defects, and cognitive dysfunction in the elderly. As a derivative of folic acid, folinic acid is useful as an antidote to folic acid antagonists (i.e., methotrexate, pyrimethamine). Folinic acid may be administered to counteract the potential toxicity of methotrexate that escapes into the systemic circulation. A clinical prospective follow up study conducted in Baghdad Hematology center of Medical city during the period from 1st of November, 2018 to 20th of April, 2019on sample of 53 Iraqi patients with hematological malignancy. The diagnosis of acute lymphoblastic leukemia or non-Hodgkin's lymphoma was done by the physicians through proper investigations. The Meth.. Read More»

    Abstract PDF

Awards Nomination

Editors List

  • Ahmed Hussien Alshewered

    University of Basrah College of Medicine, Iraq

  • Sudhakar Tummala

    Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh

     

     

     

  • Alphonse Laya

    Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis

     

  • Fava Maria Giovanna

     

  • Manuprasad Avaronnan

Flyer image
Onkologia i Radioterapia peer review process verified at publons
Flyer image
Indexed In
  • Directory of Open Access Journals
  • Scimago
  • SCOPUS
  • EBSCO A-Z
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20
View More